Multidimensional analysis suggests that ZNF433 is a promising biomarker for the diagnosis and prognosis of human cancers

Lingyu Xie^1,2Xin Zeng^1,2Hui Luo^1,2Bin Xie³Xuefeng Wang⁴Nan Wu¹Junrong Zou^2,5,6Guoxi Zhang^2,5,6Xiaofeng Zou^2,5,6Hui Xu^2,5,6*

• ¹Gannan Medical University, Ganzhou, China
• ²Department of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi Province, China
• ³Department of Urology, Shanggao County People's Hospital, Yichun, China
• ⁴Changshan County People's Hospital, Quzhou, China
• ⁵Institute of Urology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China
• ⁶Department of Urology, Jiangxi Engineering Technology Research Center of Calculi Prevention, Ganzhou, China

Background: Zinc finger proteins , particularly members of the Krüppel-associated box zinc finger proteins (KRAB-ZFPs), play critical roles in regulating gene expression, cell cycle progression, and epigenetic modifications. Despite the growing body of research on KRAB-ZFPs, the role of ZNF433, a relatively less studied member of this family, remains poorly understood in the context of cancer.Methods: We conducted multi-dimensional analyses using publicly available databases, including TCGA and GTEx, to evaluate ZNF433's expression patterns, genetic mutations, survival outcomes, immune microenvironment interactions, and diagnostic potential across different cancers. Functional enrichment and protein interaction network analyses were also performed to explore its potential inolvement in cancer-related pathways.Results: Our findings revealed that ZNF433 is significantly downregulated in most cancer types, with stage-dependent expression patterns observed in KIRC and KIRP. High expression of ZNF433 was associated with improved overall survival (OS) in HNSC and KIRC, while in ESCA and PRAD, it was correlated with poorer disease-free survival (DFS). Additionally, high ZNF433 levels were linked to better DFS in BRCA, KIRP, THYM, and KIRC. ZNF433 expression was also closely associated with genomic instability markers, including tumor mutational burden (TMB), microsatellite instability (MSI), and mismatch repair (MMR) deficiencies. Furthermore, ZNF433 exhibited significant regulatory roles within the tumor immune microenvironment. Diagnostic analysis showed that ZNF433 has strong diagnostic potential in LAML and TGCT, and moderate diagnostic value in other cancers.Conclusions: Our study highlights the potential of ZNF433 as a diagnostic and prognostic biomarker and provides new insights into its potential as a therapeutic target.